67 Cancer aneuploidy is associated with a distinct tumor immune microenvironment and impacts outcomes to immune checkpoint inhibition in nonsquamous non-small cell lung cancer

• Mark Awad,
• Gonzalo Recondo,
• Giuseppe Lamberti,
• Scott Rodig,
• Joao Victor Alessi,
• Victor Vaz,
• Adriana Barrichello,
• Yvonne Lin-Liu,
• Hersh Gupta,
• Xinan Wang,
• Andrew Cherniack,
• Kristen Felt

Affiliations

Mark Awad

Medical Oncology, Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA

Gonzalo Recondo

Medical Oncology, Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA

Giuseppe Lamberti

1Dana-Farber Cancer Institute, Boston, MA, USA

Scott Rodig

7Brigham and Women’s Hospital and Harvard, Boston, MA, USA

Joao Victor Alessi

1Dana-Farber Cancer Institute, Boston, MA, USA

Victor Vaz

1Dana-Farber Cancer Institute, Boston, MA, USA

Adriana Barrichello

1Dana-Farber Cancer Institute, Boston, MA, USA

Yvonne Lin-Liu

1DFCI, Boston, MA, USA

Hersh Gupta

1DFCI, Boston, MA, USA

Xinan Wang

2Harvard School of Public Health, Boston, MA, USA

Andrew Cherniack

1DFCI, Boston, MA, USA

Kristen Felt

1DFCI, Boston, MA, USA